Search Results 7591-7600 of 35298 for oral

1. Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Plastic Surgery · Radiation Oncology. Areas that ...

2. A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) - Mayo Clinic

   ... Oral Administration of Resmetirom (MGL-3196). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

3. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

4. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

5. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

6. An Extension Study Of Subjects Who Received An Avalyn Inhaled Antifibrotic Agent (SAIL) - Mayo Clinic

   * Subjects who experienced an exacerbation of asthma or of chronic obstructive pulmonary disease (COPD) requiring oral or systemic corticosteroids within 3 ...

7. A Study to Determine the Safety of PEP in Skin Graft Wounds - Mayo Clinic

   Located anywhere on the body (with exception of oral mucosal membranes);; Split-thickness skin graft wound depth of between 8/1000-14/1000 inch. Ability to ...

8. Plastic Surgery - Overview - Mayo Clinic

   Surgeons in Dermatology, Otorhinolaryngology (ENT)/Head and Neck Surgery and Oral and Maxillofacial Surgery also have training and expertise in reconstructive ...

9. Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies - Mayo Clinic

   inability to take oral medication;; malabsorption syndromes;; requirement for intravenous alimentation. Any active bleeding excluding hemorrhoidal or gum ...

10. A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer - Mayo Clinic

    A study cycle will consist of daily and continuous oral administration of BBI608 for four weeks (28 days) in combination with FOLFOX6 with and without ...